Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
申请人:CIBA-GEIGY AG
公开号:EP0214092A1
公开(公告)日:1987-03-11
The absorption of orally administered substantially aqueous insoluble psychoactive 2-aryl-pyrazolo [4,3-C] quinolin-3-ones of the formula
wherein R" is hydrogen, lower alkyl, lower alkoxy, hydroxy, halo or trifluoromethyl, and R'is hydrogen, lower alkyl, lower alkoxy, hydroxy, halo, trifluoromethyl, nitro, amino, mono- or di-lower alkylamino, mono- or di-lower alkylcarbamoylamino, mono- or di-lower alkylcarbamoyloxy or cyano, or a pharmaceutically acceptable salt thereof, is enhanced by administering the same in the form of a storage stable solid molecular dispersion of polyvinylpyrrolidone.
口服基本不溶于水的精神活性 2-芳基吡唑并[4,3-C]喹啉-3-酮的吸收,其式为
其中R "是氢、低级烷基、低级烷氧基、羟基、卤代或三氟甲基,R'是氢、低级烷基、低级烷氧基、羟基、卤代、三氟甲基、硝基、氨基、单或双低级烷基氨基、单或双低级烷基氨基甲酰氨基、通过以聚乙烯吡咯烷酮贮存稳定的固体分子分散体的形式给药,可增强聚乙烯吡咯烷酮的疗效。